Browse result page of Hmrbase2
This is the result page of the browse module of Hmrbase2. This page gives the information about the query submitted by the user as per the browse category. Further details of the entries can be seen by clicking on the ID. Further the user can sort the entries on the basis of various fields by clicking on the respective headers. The user can also download the results in various formats.
ID | Pubchem ID | Name | Description | Synonym | Molecular Weight | Formula | IUPAC | SMILE | PDB ID | Melting Point | Water Solubility | Receptor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
20005 | 169870 | 17-alpha-hydroxy-progesterone caproate | NA | Delalutin 17-alpha-hydroxy-progesterone caproate Primolut Depot Estralutin Hormofort Hyproval Kaprogest Syngynon Hylutin Relutin Lutate | 428.6 | C27H40O4 | [(8R;9S;10R;13S;14S;17R)-17-acetyl-10;13-dimethyl-3-oxo-2;6;7;8;9;11;12;14;15;16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate | CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C | NA | NA | NA | P06401; P06186; P5966720009 | 636374 | Alclometasone dipropionate | NA | Aclovate alclometasone dipropionate alclometasone Aclosone Legederm Modrasone Delonal Almeta Vaderm | 521.04 | C28H37ClO7 | [(7R;8S;9S;10R;11S;13S;14S;16R;17R)-7-chloro-11-hydroxy-10;13;16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-7;8;9;11;12;14;15;16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate | CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3C2C(CC4=CC(=O)C=CC34C)Cl)O)C)C)OC(=O)CC | NA | NA | NA | NA | 20012 | 32327 | Algestone Acetophenide | A progesterone that has been used in ESTRUS SYNCHRONIZATION and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also used therapeutically as a topical anti-inflammatory and is applied topically in the treatment of ACNE. | Deladroxone Bovitrol Neolutin Droxone Algeston acetofenid P-Dhp Alphasone acetophenide | 448.59 | C29H36O4 | NA | CC(=O)C12C(CC3C1(CCC4C3CCC5=CC(=O)CCC45C)C)OC(O2)(C)C6=CC=CC=C6 | NA | 150.5 | NA | NA | 20019 | 20469 | Beclomethasone | An anti-inflammatory; synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA. | beclomethasone Becotide Beclometason Beclocort | 408.92 | C22H29ClO5 | (8S;9R;10S;11S;13S;14S;16S;17R)-9-chloro-11;17-dihydroxy-17-(2-hydroxyacetyl)-10;13;16-trimethyl-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-3-one | CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C | NA | NA | NA | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20020 | 21700 | Beclomethasone dipropionate | An anti-inflammatory; synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA. | Beclovent Beclomethasone Vanceril Becloturmant Becloforte Beclorhinol Sanasthmax Sanasthmyl Aldecina Aldecine Beclacin | 521.04 | C28H37ClO7 | [(8S;9R;10S;11S;13S;14S;16S;17R)-9-chloro-11-hydroxy-10;13;16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC | NA | NA | NA | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20022 | 16533 | Betamethasone 17-Valerate | The 17-valerate derivative of BETAMETHASONE. It has substantial topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity. | beta-Val Betnovateat Celestoderm Betatrex Betnovate Betamethasone 17-Valerate Valisone Luxiq Betaderm Dermabet Valnac | 476.58 | C27H37FO6 | [(8S;9R;10S;11S;13S;14S;16S;17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10;13;16-trimethyl-3-oxo-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate | CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO | NA | 222 | 9.29mg/ml at 25C | P04150 | 20023 | 65478 | betamethasone sodium phosphate | phosphate ester of betamethasone; RN given refers to the di-Na salt (11beta;16beta)-isomer; structure in Negwer;5th ed; 4975 | Bentelan betamethasone sodium phosphate Betnesol Celestone Linolosal Linosal Celestone Soluspan Celestone Phosphate Betasone (Veterinary) beta-Methasone phosphate | 516.4 | C22H28FNa2O8P | disodium[2-[(8S;9R;10S;11S;13S;14S;16S;17R)-9-fluoro-11;17-dihydroxy-10;13;16-trimethyl-3-oxo-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate | CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+] | NA | NA | NA | P04150 | 20026 | 3033890 | Budesonide | A glucocorticoid used in the management of ASTHMA; the treatment of various skin disorders; and allergic RHINITIS. | budesonide Cortivent Entocort Micronyl Preferid Pulmicort Respules Rhinocort Spirocort Budeson | 430.53 | C25H34O6 | NA | CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C | NA | 226 | NA | P04150 | 20028 | 5311051 | Clobetasol | A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE; it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. | clobetasol Clobecort Amex | 410.91 | C22H28ClFO4 | (8S;9R;10S;11S;13S;14S;16S;17R)-17-(2-chloroacetyl)-9-fluoro-11;17-dihydroxy-10;13;16-trimethyl-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-3-one | CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C | NA | NA | NA | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20029 | 32798 | Clobetasol propionate | A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE; it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. | Clobex Clobetasol Clobesol Dermovate Temovate Cormax Luxiq Temovate E Embeline Olux | 466.97 | C25H32ClFO5 | [(8S;9R;10S;11S;13S;14S;16S;17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10;13;16-trimethyl-3-oxo-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl | NA | 222.5 | 3.86mg/ml at 25C | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20030 | 71386 | Clobetasone butyrate | NA | Eumovate Molivate Kindavate Trimovate Emovate Kindavate (TN) Clobetasone 17-butyrate clobetasone butyrate | 478.98 | C26H32ClFO5 | [(8S;9R;10S;13S;14S;16S;17R)-17-(2-chloroacetyl)-9-fluoro-10;13;16-trimethyl-3;11-dioxo-7;8;12;14;15;16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butanoate | CCCC(=O)OC1(C(CC2C1(CC(=O)C3(C2CCC4=CC(=O)C=CC43C)F)C)C)C(=O)CCl | NA | 95 | 0.6mg/ml at 25C | NA | 20043 | 16752 | Dexamethasone Isonicotinate | An anti-inflammatory; anti-allergic glucocorticoid that can be administered orally; by inhalation; locally; and parenterally. It may cause water and salt retention. | Auxiloson Auxilson Auxilsone Voren Auxison Dexamethasone 21-isonicotinate Dexamethasone Isonicotinate | 497.56 | C28H32FNO6 | [2-[(8S;9R;10S;11S;13S;14S;16R;17R)-9-fluoro-11;17-dihydroxy-10;13;16-trimethyl-3-oxo-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl]pyridine-4-carboxylate | CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C5=CC=NC=C5)O)C)O)F)C | NA | NA | NA | NA | 20047 | 71414 | Diflorasone diacetate | RN given refers to (6alpha;11beta;16beta)-isomer; structure | Florone diflorasone diacetate Psorcon Maxiflor diflorasone diacetate diflorasone Apexicon e Psorcon (TN) Diflorasone di(acetate) | 494.52 | C26H32F2O7 | [(6S;8S;9R;10S;11S;13S;14S;16S;17R)-17-(2-acetyloxyacetyl)-6;9-difluoro-11-hydroxy-10;13;16-trimethyl-3-oxo-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-17-yl] acetate | CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F | NA | NA | NA | NA | 20050 | 9305 | Diiodotyrosine | A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones; diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE). | L-Diiodotyrosine 3;5-Diiodo-L-tyrosine DIT (amino acid) L-3;5-Diiodotyrosine 3;5-L-Diiodotyrosine 3;5-Iodo-L-tyrosine 3;5-DIIODOTYROSINE L-Tyrosine; 3;5-diiodo- | 432.98 | C9H9I2NO3 | (2S)-2-amino-3-(4-hydroxy-3;5-diiodophenyl)propanoic acid | C1=C(C=C(C(=C1I)O)I)CC(C(=O)O)N | NA | NA | 617mg/ml at 25C | NA | 20052 | 19212 | alpha-Ecdysone | A steroid hormone that regulates the processes of MOLTING or ecdysis in insects. | alpha-Ecdysone Ecdysone | 464.63 | C27H44O6 | (2S;3R;5R;9R;10R;13R;14S;17R)-17-[(2S;3R)-3;6-dihydroxy-6-methylheptan-2-yl]-2;3;14-trihydroxy-10;13-dimethyl-2;3;4;5;9;11;12;15;16;17-decahydro-1H-cyclopenta[a]phenanthren-6-one | CC(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)C(CCC(C)(C)O)O | NA | NA | NA | NA | 20053 | 5459840 | Ecdysterone | A steroid hormone that regulates the processes of MOLTING or ecdysis in insects. Ecdysterone is the 20-hydroxylated ECDYSONE. | Ecdysterone beta-Ecdysone Polypodine A Crustecdysone Isoinokosterone Viticosterone Commisterone Crustecdyson Ecdysteron 20-HYDROXYECDYSONE | 480.63 | C27H44O7 | (2S;3R;5R;9R;10R;13R;14S;17S)-2;3;14-trihydroxy-10;13-dimethyl-17-[(2R;3R)-2;3;6-trihydroxy-6-methylheptan-2-yl]-2;3;4;5;9;11;12;15;16;17-decahydro-1H-cyclopenta[a]phenanthren-6-one | CC12CCC3C(=CC(=O)C4C3(CC(C(C4)O)O)C)C1(CCC2C(C)(C(CCC(C)(C)O)O)O)O | 2R40 | NA | NA | P17672; P13055; P17671; O01639; P50239; Q08893; P45447; P49880; P49881; P49882; P34021; O18473; O18531; P49883 | 20067 | 16490 | Flumethasone | An anti-inflammatory glucocorticoid used in veterinary practice. | Flumethasone Flucorticin Flumethason Cortexilar Anaprime Aniprime Methagon Flucort Fluvet | 410.45 | C22H28F2O5 | (6S;8S;9R;10S;11S;13S;14S;16R;17R)-6;9-difluoro-11;17-dihydroxy-17-(2-hydroxyacetyl)-10;13;16-trimethyl-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-3-one | CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F | NA | NA | 1mg/ml at 20C | NA | 20068 | 6215 | Fluocinolone Acetonide | A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream; gel; lotion; or ointment. It has also been used topically in the treatment of inflammatory eye; ear; and nose disorders. (From Martindale; The Extra Pharmacopoeia; 30th ed; p | Synandone Synalar Fluocinolone Acetonide Synandrone Coriphate Fluovitif Flupollon Percutina Dermalar Flucinar Fluocinolone Acetonide | 452.49 | C24H30F2O6 | NA | CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C | NA | 265.5 | 11mg/ml at 25C | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20069 | 9642 | Fluocinonide | A topical glucocorticoid used in the treatment of ECZEMA. | Fluocinonide Lidex Fluocinonide Vanos Bestasone Biscosal Cortalar Flucinar Straderm Topsymin | 494.52 | C26H32F2O7 | NA | CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C | NA | 309 | 4.74mg/ml at 25C | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20074 | 15209 | Flurandrenolone | A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment; and is also used as a polyethylene tape with an adhesive. (From Martindale; The Extra Pharmacopoeia; 30th ed; p733) | Flurandrenolone Fludroxycortide Cordran Fludroxicortidum Drenison Drocort Sermaka Haelan | 436.51 | C24H33FO6 | NA | CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C | NA | 251 | NA | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20082 | 5920 | Triiodothyronine | A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the t | liothyronine Triiodothyronine Liothyronin L-Liothyronine triothyrone Lyothyronine Tresitope Tri-Thyrotope T3 liothyronine Triiodo-L-thyronine | 650.97 | C15H12I3NO4 | (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3;5-diiodophenyl]propanoicacid | C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O | 1BSX;1SN5;1XZX;2H6W;2H77;2H79;2PIV;2PIW | 236.5 | 3.96mg/ml at 37C | P10827; P10828; P37243 | 20085 | 30605 | Mepitiostane | orally active anti-estrogenic steroid; RN refers to (2alpha;3alpha;5alpha;17beta)-isomer; structure | Mepitiostane Mepitiostanum Mepitiostano | 404.65 | C25H40O2S | NA | CC12CCC3C(C1CCC2OC4(CCCC4)OC)CCC5C3(CC6C(C5)S6)C | NA | NA | NA | NA | 20092 | 16923 | Methylprednisolone Hemisuccinate | A water-soluble ester of METHYLPREDNISOLONE used for cardiac; allergic; and hypoxic emergencies. | Solumedrol Methylprednisolone Hemisuccinate Urbason-Soluble A-Methapred Solu-Medrol Methylprednisolone succinate | 474.54 | C26H34O8 | 4-[2-[(6S;8S;9S;10R;11S;13S;14S;17R)-11;17-dihydroxy-6;10;13-trimethyl-3-oxo-7;8;9;11;12;14;15;16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid | CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O | NA | NA | NA | P04150 | 20093 | 23680530 | Methylprednisolone sodium succinate | A water-soluble ester of METHYLPREDNISOLONE used for cardiac; allergic; and hypoxic emergencies. | A-Methapred Methylprednisolone Hemisuccinate Solu-Medrol Asmacortone Metypresol Corticel Emmetipi Metypred Prednilem Firmacort Fiale Nirypan solubile | 496.53 | C26H33NaO8 | sodium4-[2-[(6S;8S;9S;10R;11S;13S;14S;17R)-11;17-dihydroxy-6;10;13-trimethyl-3-oxo-7;8;9;11;12;14;15;16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate | CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O.[Na+] | NA | NA | NA | P04150 | 20096 | 9677 | Nandrolone decanoate | structure; used in the treatment of HIV wasting disease | Retabolil nandrolone decanoate Deca-Durabolin naboline Deca-Hybolin Decadurabolin nandrolone decanoate Decadurobolin nandrolone decanoate Adenocorin Salistoperm Superbolan Anabolin | 428.65 | C28H44O3 | [(8R;9S;10R;13S;14S;17S)-13-methyl-3-oxo-2;6;7;8;9;10;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]decanoate | CCCCCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C | NA | NA | NA | NA | 20102 | 6714002 | Prednicarbate | NA | Dermatop Peitel PREDNICARBATE Dermatop (TN) Dermatop E emollient | 488.57 | C27H36O8 | [2-[(8S;9S;10R;11S;13S;14S;17R)-17-ethoxycarbonyloxy-11-hydroxy-10;13-dimethyl-3-oxo-7;8;9;11;12;14;15;16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC | NA | NA | NA | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20110 | 22069 | Reverse T3 | A metabolite of THYROXINE; formed by the peripheral enzymatic monodeiodination of T4 at the 5 position of the inner ring of the iodothyronine nucleus. | Reverse T3 Triiodothyronine; reverse Triiodothyronine; Reverse 3;3';5'-Triiodothyronine Triiodothyronine; Reverse REVERSE TRIIODOTHYRONINE Triiodothyronine; Reverse 3;3';5'-Triiodo-L-thyronine T0 | 650.97 | C15H12I3NO4 | 2-amino-3-[4-(4-hydroxy-3;5-diiodophenoxy)-3-iodophenyl]propanoic acid | C1=CC(=C(C=C1CC(C(=O)O)N)I)OC2=CC(=C(C(=C2)I)O)I | NA | NA | NA | NA | 20114 | 6012 | Testosterone 17 beta-cypionate | NA | Depovirin Jectatest Pertestis Durandro Andro-Cyp Depo-Testosterone testosterone 17 beta-cypionate Dep-Test Malogen CYP Depo-Testadiol Testodrin prolongatum | 412.6 | C27H40O3 | (10;13-dimethyl-3-oxo-1;2;6;7;8;9;11;12;14;15;16;17-dodecahydrocyclopenta[a]phenanthren-17-yl) 3-cyclopentylpropanoate | CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C | NA | NA | NA | Q9TT90; Q8MIK0; O97776; P10275; O97952; Q6QT55; P19091; O97775; O97960; Q9GKL7; P49699; Q7T1K4; P15207; O18925; O18928; O55065; O55066; O93244; O93245 | 20116 | 5819 | L-thyroxine | The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is | L-thyroxine Thyroxine levothyroxine synthroid thyroxin Thyroxine iodine Levothyroxin Thyreoideum Thyratabs Thyroxinal | 776.87 | C15H11I4NO4 | (2S)-2-amino-3-[4-(4-hydroxy-3;5-diiodophenoxy)-3;5-diiodophenyl]propanoicacid | C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N | 1ICT;1IE4;1HK1;1HK2;1HK3;1HK4;1HK5;1SN0;1Y0X;2CEO;2ROX;2RIW;1ETA;1ETB | 235.5 | 1.05E-04mg/ml at 25C | P10828; P10827 | 20120 | 6436 | Triamcinolone Acetonide | An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional; intramuscular; and intra-articular injections are also administered under certain conditions. | Kenalog Triamcinolone Acetonide Polcortolon Aristoderm Aristogel Triaceton Tricinolon Azmacort Triamcinolone Acetonide Kenalone Nasacort Solodelf | 434.5 | C24H31FO6 | NA | CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C | NA | 293 | 21mg/ml at 28C | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20130 | NA | 5a-Cholestane-3a;7a;12a;25-tetrol | 5a-Cholestane-3a;7a;12a;25-tetrol is a bile alcohols which is excreted mainly as glucurono-conjugates in bile and urine; and as unconjugated form in feces of patients with cerebrotendinous xanthomatosis (PMID 3700361) | 5a-Cholestane-3a;7a;12a;25-tetrol | 436.67 | C27H48O4 | (3a;5a;7a;12a)-Cholestane-3;7;12;25-tetrol | CC(CCCC(C)(C)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C | NA | NA | NA | NA | 20133 | 119394 | Campestanol | NA | Campestanol Campestan-3beta-ol 24beta-Ethylcholestanol 5alpha-Dihydrocampesterol 24beta-Methyl cholestanol 5alpha-campestan-3beta-ol 5alpga-Ergostan-3-beta-ol (24R)-5alpha-ergostan-3beta-ol | 402.7 | C28H50O | (3S;5S;8R;9S;10S;13R;14S;17R)-17-[(2R;5R)-5;6-dimethylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C | NA | NA | NA | NA | 20137 | 636741 | Sitosterol | RN given refers to cpd without isomeric designation; structure in first source | Clionasterol sitosterol GAMMA-SITOSTEROL (24alphaFH)-stigmast-5-en-3beta-ol (3beta;8xi;9xi;10xi;13xi;14xi;17xi;24S)-stigmast-5-en-3-ol stigmast-5-en-3-ol; (3beta;8xi;9xi;10xi;13xi;14xi;17xi;24S)- | 414.71 | C29H50O | (3S;8R;9R;10S;13R;14S;17R)-17-[(2R;5S)-5-ethyl-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | NA | NA | NA | Q9YHT3; P49884; P06212; Q91424; P57717; Q53AD2; Q9TV98; P03372; Q9YHZ7; P49886; Q9QZJ5; P57753; P19785; P16058; P50240; Q9YH33; P50241; O42132; Q29040 | 20139 | NA | Tauroursocholic acid | Tauroursocholic acid is a bile acid formed in the liver by conjugation of deoxycholate with taurine; usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute; depends only on presence or absence of hydroxy | Tauroursocholate#Tauroursocholic acid#Ursocholyltaurine | 515.7 | C26H45NO7S | 2-[[(3a;5b;7b;12a)-3;7;12-trihydroxy-24-oxocholan-24-yl]amino]-Ethanesulfonic acid | CC(CCC(=O)NCCS(O)(=O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C | NA | NA | NA | NA | 20142 | NA | Taurallocholic acid | An ethanesulfonic acid derivative of Cholane. Tauroallocholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute; depends only on presence or absence of hydroxyl groups on positions 3; 7; and 12. | Taurallocholate#Taurallocholic acid | 515.7 | C26H45NO7S | 2-[[(3a;5a;7a;12a)-3;7;12-trihydroxy-24-oxocholan-24-yl]amino]-Ethanesulfonic acid | CC(CCC(=O)NCCS(O)(=O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C | NA | NA | NA | NA | 20145 | 133187 | 32-oxolanosterol | found in mevalonate-treated cell cultures | 32-Oxolanosterol 32-Ketolanosterol Lanosta-8;24-dien-30-al; 3-hydroxy-; (3beta)- | 440.7 | C30H48O2 | (3S;10S;13R;14S;17R)-3-hydroxy-4;4;10;13-tetramethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2;3;5;6;7;11;12;15;16;17-decahydro-1H-cyclopenta[a]phenanthrene-14-carbaldehyde | CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C=O | NA | NA | NA | NA | 20147 | 5284208 | 5beta-Cholestane-3alpha;7alpha;12alpha;23-tetrol | NA | 5beta-Cholestane-3alpha;7alpha;12alpha;23-tetrol | 436.67 | C27H48O4 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-17-[(2R)-4-hydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(C)CC(CC(C)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C)O | NA | NA | NA | NA | 20148 | 132886 | 27-norcholestane-3;7;12;24;25-pentol | bile alcohol found in urine | 27-Norcholestane-3;7;12;24;25-pentol 26(or 27)-Norcholestane-3;7;12;24;25-pentol 27-NC-3;7;12;24;25-PO 27-Nor-5beta-cholestane-3alpha;7alpha;12alpha;24;25-pentol 27-Norcholestane-3;7;12;24;25-pentol; | 438.64 | C26H46O5 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17S)-17-[(2R)-5;6-dihydroxyheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CCC(C(C)O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20150 | NA | 7a;12a-Dihydroxy-cholestene-3-one | 7a;12a-Dihydroxy-cholestene-3-one is an intermediate in bile acid synthesis; is considerably higher in patients with cerebrotendinous xanthomatosis (CTX) than in the normal liver. (PMID 7017048) | 7-alpha;12-alpha-dihydroxy-4-cholesten-3-one#7-alpha;12-alpha-dihydroxycholest-4-en-3-one#7-a;12-a-dihydroxy-4-cholesten-3-one#7-a;12-a-dihydroxycholest-4-en-3-one#7alpha;12alpha-Dihydroxy-cholestene- | 416.64 | C27H44O3 | NA | CC(C)CCCC(C)C1CCC2C3C(O)CC4CC(=O)C=CC4(C)C3CC(O)C12C | NA | NA | NA | NA | 20151 | 194244 | Taurochenodeoxycholate-3-sulfate | NA | TCDCS Taurochenodeoxycholate-3-sulfate Taurochenodeoxycholate-3-sulfate conjugate Ethanesulfonic acid; 2-(((3alpha;5beta;7alpha)-7-hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl)am ino)-; (S)- | 579.77 | C26H45NO9S2 | 2-[[(4R)-4-[(3R;5R;7R;10S;13R;17R)-7-hydroxy-10;13-dimethyl-3-sulfooxy-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)OS(=O)(=O)O)C)O)C | NA | NA | NA | NA | 20152 | 451487 | Taurolithocholic acid 3-sulfate | NA | Taurolithocholic acid 3-sulfate Ethanesulfonic acid; 2-(((3.alpha.; 5.beta.)-24-oxo-3-(sulfooxy)cholan-24-yl)amino)- | 563.77 | C26H45NO8S2 | 2-[[(4R)-4-[(3R;5R;8R;10S;13R;14S;17R)-10;13-dimethyl-3-sulfooxy-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)OS(=O)(=O)O)C)C | NA | NA | NA | NA | 20153 | NA | Taurocholic acid 3-sulfate | Taurocholic acid 3-sulfate is a sulfated bile acid. It is a sulfate salt of taurocholic acid and is also known as cholaic acid; cholyltaurine; or acidum cholatauricum. Under normal circumstances; bile acid sulfation is a minor pathway. However in the presence of cholestasis; the fraction of the bile | 3-Sulfocholyltaurine#Taurocholic acid 3-sulfate#Taurocholic acid 3-sulfic acid#Taurocholic acid 3a-sulfate | 595.77 | C26H45NO10S2 | 2-[[(3a;5b;7a;12a)-7;12-dihydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]amino]-ethanesulfonic acid | CC(CCC(=O)NCCS(O)(=O)=O)C1CCC2C3C(O)CC4CC(CCC4(C)C3CC(O)C12C)OS(O)(=O)=O | NA | NA | NA | NA | 20156 | 167685 | 22-hydroxycholesterol | NA | 22R-hydroxycholesterol 22-hydroxycholesterol 22(R)-Hydroxycholesterol 22beta-Hydroxycholesterol 22alpha-Hydroxycholesterol (22R)-22-Hydroxycholesterol cholest-5-en-3beta;22R-diol 5-Cholestene-3be | 402.65 | C27H46O2 | (3S;8S;9S;10R;13S;14S;17R)-17-[(2S;3R)-3-hydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CC(C)CCC(C(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O | NA | NA | NA | Q3SZL0; Q96RI1; Q60641; Q62735; Q811W9; Q811X0; Q811X1; Q811X2; Q8JHU2 | 20157 | 440711 | 20-hydroxycholesterol | RN given refers to (20S)-isomer | 20alpha-Hydroxycholesterol (3BETA;20R)-CHOLEST-5-ENE-3;20-DIOL (3S;8S;9S;10R;13S;14S;17S)-17- -10;13-dimethyl-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopent aphenanthren-3-ol | 402.65 | C27H46O2 | (3S;8S;9S;10R;13S;14S;17S)-17-[(2R)-2-hydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CC(C)CCCC(C)(C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O | 1ZHW | NA | NA | NA | 20171 | 644042 | 17-hydroxypregnenolone sulfate | RN given refers to unspecified sulfate position in Chemline | 17OH-Psulf 17-Hydroxypregnenolone sulfate 17-Hydroxypregnenolone 3-sulfate 17alpha-Hydroxypregnenolone sulfate 17alpha-Hydroxypregnenolone 3-sulfate pregn-5-en-20-one; 17-hydroxy-3-(sulfooxy)-; (3b | 412.54 | C21H32O6S | [(3S;8R;9S;10R;13S;14S;17R)-17-acetyl-17-hydroxy-10;13-dimethyl-1;2;3;4;7;8;9;11;12;14;15;16-dodecahydrocyclopenta[a]phenanthren-3-yl] hydrogensulfate | CC(=O)C1(CCC2C1(CCC3C2CC=C4C3(CCC(C4)OS(=O)(=O)O)C)C)O | NA | NA | NA | NA | 20174 | 5284212 | 5beta-Cholestane-3alpha;7alpha;12alpha;23;25-pentol | NA | 5beta-Cholestane-3alpha;7alpha;12alpha;23;25-pentol | 452.67 | C27H47O5 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-17-[(2R)-4;6-dihydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CC(CC(C)(C)O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20176 | NA | 5b-Cholestane-3a;7a;12a;23R;25-pentol | 5b-Cholestane-3a;7a;12a;23R;25-pentol is a bile alcohol present in the urine of patients with cerebrotendinous xanthomatosis; but not in feces. A possible explanation for the urinary cholestanepentols is that the major serum bile alcohol; 5b-cholestane-3a;7a;12a;25-tetrol; might be hydroxylated at C | 17-(3;5-dihydroxy-1;5-dimethyl-hexyl)-10;13-dimethyl-hexadecahydro-cyclopenta[a]phenanthrene-3;7;12-triol#5b-Cholestane-3a;7a;12a;23R;25-pentol | 452.67 | C27H48O5 | NA | CC(CC(O)CC(C)(C)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C | NA | NA | NA | NA | 20177 | 5284213 | 5beta-Cholestane-3alpha;7alpha;12alpha;24;25-pentol | NA | 5beta-Cholestane-3alpha;7alpha;12alpha;24;25-pentol | 452.67 | C27H48O5 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-17-[(2R)-5;6-dihydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CCC(C(C)(C)O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20178 | 5284250 | 5alpha-Cholestane-3alpha;7alpha;12alpha;23;25-pentol | NA | 5alpha-Cholestane-3alpha;7alpha;12alpha;23;25-pentol | 452.67 | C27H48O5 | (3R;5R;7R;8R;9S;10S;12S;13R;14S;17R)-17-[(2R)-4;6-dihydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CC(CC(C)(C)O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20180 | 65076 | Cholesteryl sulfate | component of human seminal plasma and spermatozoa; RN given refers to (3beta)-isomer | Cholesterol sulfate Cholesteryl sulfate Chol-sulf Cholesterol 3-sulfate Y5-Cholesten-3beta-yl sulfate Cholest-5-en-3beta-ol sulfate | 466.72 | C27H46O4S | [(3S;8S;9S;10R;13R;14S;17R)-10;13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OS(=O)(=O)O)C)C | 1S0X;2HKA | NA | NA | P35398 | 20181 | 167758 | Cholestane-3;7;12;25-tetrol | bile alcohol; structure in 4th source | Cholestane-3;7;12;25-tetrol 5beta-Cholestane-3alpha;7alpha;12alpha;25-tetrol 5beta-Cholestane-3beta;7alpha;12alpha;25-tetrol Cholestane-3;7;12;25-tetrol; (3alpha;5beta;7alpha;12alpha)- | 436.67 | C27H48O4 | (3R;5S;7R;8R;9S;10S;12S;13R;14S)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CCCC(C)(C)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20183 | 10594 | Taurodeoxycholic Acid | A bile salt formed in the liver by conjugation of deoxycholate with taurine; usually as the sodium salt. It is used as a cholagogue and choleretic; also industrially as a fat emulsifier. | Taurodeoxycholate Deoxycholyltaurine Taurine Deoxycholate TAURODEOXYCHOLIC ACID SODIUM TAURODEOXYCHOLATE Ethanesulfonic acid; 2-(((3alpha;5beta;12alpha)-3;12-dihydroxy-24-oxocholan-24-yl)amino)- | 499.7 | C26H45NO6S | 2-[4-[(3R;5R;8R;9S;10S;12S;13R;14S;17R)-3;12-dihydroxy-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid | CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C | NA | NA | NA | Q3SZL0; Q96RI1; Q60641; Q62735 | 20185 | 10591 | Taurochenodeoxycholic Acid | A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine; usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic. | Taurochenodeoxycholate Chenodeoxycholyltaurine Taurine chenodeoxycholate TAUROCHENODEOXYCHOLIC ACID Ethanesulfonic acid; 2-(((3alpha;5beta;7alpha)-3;7-dihydroxy-24-oxocholan-24-yl)amino)- | 499.7 | C26H45NO6S | 2-[4-[(3R;5S;7R;8R;9S;10S;13R;14S;17R)-3;7-dihydroxy-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid | CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C | NA | NA | NA | Q3SZL0; Q96RI1; Q60641; Q62735 | 20188 | 443212 | 4;4-dimethylcholesta-8;14;24-trienol | a meiosis activating sterol; RN given refers to (5alpha;3beta)-isomer | 4;4-Dimechol-8;14;24-trienol 4;4-Dimethylcholesta-8;14;24-trienol 4;4-Dimethyl-5alpha-cholesta-8;14;24-trien-3beta-ol (3beta;5alpha)-4;4-Dimethylcholesta-8;14;24-trien-3-ol Cholesta-8;14;24-trien-3-o | 410.67 | C29H46O | (3S;5R;10S;13R;17R)-4;4;10;13-tetramethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1;2;3;5;6;7;11;12;16;17-decahydrocyclopenta[a]phenanthren-3-ol | CC(CCC=C(C)C)C1CC=C2C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C | NA | NA | NA | NA | 20191 | 656456 | 4alpha-formyl-5alpha-cholesta-8;24-dien-3beta-ol | NA | 4alpha-formyl-5alpha-cholesta-8;24-dien-3beta-ol | 412.65 | C28H44O2 | 3-hydroxy-10;13-dimethyl-17-(6-methylhept-5-en-2-yl)-2;3;4;5;6;7;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carbaldehyde | CC(CCC=C(C)C)C1CCC2C1(CCC3=C2CCC4C3(CCC(C4C=O)O)C)C | NA | NA | NA | NA | 20193 | 656449 | 4;4-dimethyl-14alpha-hydroxymethyl-5alpha-cholesta-8;24-dien-3beta-ol | NA | 4;4-dimethyl-14alpha-hydroxymethyl-5alpha-cholesta-8;24-dien-3beta-ol | 442.72 | C30H50O2 | 14-(hydroxymethyl)-4;4;10;13-tetramethyl-17-(6-methylhept-5-en-2-yl)-2;3;5;6;7;11;12;15;16;17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)CO | NA | NA | NA | NA | 20194 | 440375 | 4;4-Dimethyl-5alpha-cholest-7-en-3beta-ol | NA | 4;4-Dimethyl-5alpha-cholest-7-en-3beta-ol | 414.71 | C29H50O | (3S;5R;10R;13R;14R;17R)-4;4;10;13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1;2;3;5;6;9;11;12;14;15;16;17-dodecahydrocyclopenta[a]phenanthren-3-ol | CC(C)CCCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4(C)C)O)C)C | NA | NA | NA | NA | 20195 | 5710148 | 25-Hydroxyvitamin D2 | 9;10-Secoergosta-5;7;10(19);22-tetraene-3;25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3. | 25-Hydroxycalciferol 25-Hydroxyvitamin D 2 25-Hydroxyvitamin D 25-Hydroxyergocalciferol | 412.65 | C28H44O2 | (1S;3Z)-3-[(2E)-2-[(1R;3aS;7aR)-1-[(E;2R;5S)-6-hydroxy-5;6-dimethylhept-3-en-2-yl]-7a-methyl-2;3;3a;5;6;7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C | NA | NA | NA | NA | 20197 | 405 | Cholest-5-en-3 beta;7 alpha-diol | substrate for hydroxysteroid dehydrogenase; RN given refers to (3beta;7alpha)-isomer | 7beta-Hydroxycholesterol cholest-5-en-3 beta;7alpha-diol 7alpha-Hydroxycholesterol 5-cholestene-3beta;7beta-diol | 402.65 | C27H46O2 | 10;13-dimethyl-17-(6-methylheptan-2-yl)-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthrene-3;7-diol | CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C | NA | NA | NA | NA | 20199 | 123743 | 7 alpha-hydroxy-4-cholesten-3-one | structure | Cholest-4-en-7alpha-ol-3-one 7-Hydroxycholest-4-en-3-one 7alpha-Hydroxy-4-cholesten-3-one 7 alpha-hydroxy-4-cholesten-3-one Cholest-4-en-3-one; 7-hydroxy-; (7alpha)- | 400.64 | C27H44O2 | (7R;8S;9S;10R;13R;14S;17R)-7-hydroxy-10;13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1;2;6;7;8;9;11;12;14;15;16;17-dodecahydrocyclopenta[a]phenanthren-3-one | CC(C)CCCC(C)C1CCC2C1(CCC3C2C(CC4=CC(=O)CCC34C)O)C | NA | NA | NA | NA | 20201 | NA | (3a;5b;7a;12a)-24-[(carboxymethyl)amino]-1;12-dihydroxy-24-oxocholan-3-yl-b-D-Glucopyranosiduronic a | b-D-GlucopyranosIduronic acid; (3a;5b;7a;12a)-24-[(carboxymethyl)amino]-1;12-dihydroxy-24-oxocholan-3-yl is found in the urine of leprosy patients. It is red in color similar to clofazimine. It is considered more polar than the parent drug. It is formed by hydrolytic deamination followed by glucuro | Glycocholic acid 3-glucuronide | 641.75 | C32H51NO12 | (3a;5b;7a;12a)-24-[(carboxymethyl)amino]-1;12-dihydroxy-24-oxocholan-3-yl b-D-glucopyranosiduronic acid | CC(CCC(=O)NCC(O)=O)C1CCC2C3C(O)CC4CC(CCC4(C)C3CC(O)C12C)OC1OC(C(O)C(O)C1O)C(O)=O | NA | NA | NA | NA | 20202 | 6455391 | Taurochenodeoxycholate-7-sulfate | affects bile flow and biliary lipids; RN refers to di-Na salt; structure given in first source | Tcdc-7-S Taurochenodeoxycholate-7-sulfate Ethanesulfonic acid; 2-(((3alpha;5beta;7alpha)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-yl)am ino)-; disodium salt | 623.73 | C26H45NO9S2 | disodium2-[[(4R)-4-[(3R;5S;7R;10S;13R;17R)-3-hydroxy-10;13-dimethyl-7-sulfonatooxy-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate | CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)OS(=O)(=O)[O-])C.[Na+].[Na+] | NA | NA | NA | NA | 20206 | 161671 | Withanolide D | structure | Withanolide D 5;6-Epoxy-4;20;22-trihydroxy-1-oxoergosta-2;24-dien-26-oic acid delta-lactone (4beta;5beta;6beta;22R)-5;6-Epoxy-4;20;22-trihydroxy-1-oxoergosta- 2;24-dien-26-oic acid; delta-lactone | 470.6 | C28H38O6 | NA | CC1=C(C(=O)OC(C1)C(C)(C2CCC3C2(CCC4C3CC5C6(C4(C(=O)C=CC6O)C)O5)C)O)C | NA | NA | NA | NA | 20208 | 91498 | Cholestane-3;5;6-triol | structure; RN given refers to cpd without isomeric designation | 5alpha;6beta-Dihydroxycholestanol 3beta;5alpha;6beta-Cholestanetriol Cholesta-3beta;5alpha;6beta-triol 5-alpha;6-beta-Dihydroxycholestanol 3beta;5alpha;6beta-Trihydroxycholestane | 420.67 | C27H48O3 | (3S;5R;6R;8S;9S;10R;13R;14S;17R)-10;13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1;2;3;4;6;7;8;9;11;12;14;15;16;17-tetradecahydrocyclopenta[a]phenanthrene-3;5;6-triol | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20210 | 65094 | 25-hydroxycholesterol | structure; RN given refers to cpd without isomeric designation | 25-Hydroxycholesterol 5-Cholestene-3beta;25-diol Cholest-5-ene-3beta;25-diol cholest-5-en-3beta;25-diol 25-Hydroxycholest-5-en-3-ol | 402.65 | C27H46O2 | (3S;8S;9S;10R;13R;14S;17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CC(CCCC(C)(C)O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C | 1ZHX | NA | NA | NA | 20213 | 440985 | Cholest-5-ene-3;7;27-triol | NA | NA | 418.65 | C27H46O3 | (3S;7S;8S;9S;10R;13R;14S;17R)-17-[(2R)-7-hydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthrene-3;7-diol | CC(CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C)CO | NA | NA | NA | NA | 20225 | 6743 | Stigmastanol | saturated analog of beta-sitosterol; RN given refers to (3beta;5alpha)-isomer | Fucostanol Spinastanol Dihydrositosterin sitostanol stigmastanol STIGMASTANOL stigmastanol beta-Sitostanol Dihydrositosterol 24alpha-Ethylcholestanol Stigmastane-3-beta-ol beta-Sitosterol; dihy | 416.72 | C29H52O | 17-(5-ethyl-6-methylheptan-2-yl)-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol | CCC(CCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C)C(C)C | NA | 9.73 | NA | NA | 20229 | 3034759 | Tauroursodeoxycholic acid | RN given refers to (3alpha;5beta;7beta)-isomer | Ursodeoxycholyltaurine Tauroursodeoxycholic acid TUDCA Tauroursodeoxycholic acid (6CI;7CI) tauroursodeoxycholic acid; (3alpha;5alpha;7alpha)-isomer | 499.7 | C26H45NO6S | 2-[[(4R)-4-[(3R;5S;7S;10S;13R;17R)-3;7-dihydroxy-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C | NA | NA | NA | NA | 20232 | 6438368 | 1;25-dihydroxyvitamin D3-26;23-lactone | NA | 1;25-Lactone Calcitriol-26;23-lactone 1;25-dihydroxyvitaminD3-26;23-lactone 1;25-Dihydroxycholecalciferol-26-23-lactone 1alpha;25-Dihydroxyvitamin D3-26;23-lactone 23(S);25(R)-1;25(OH)2D3-26;23-Lact | 444.6 | C27H40O5 | (3R;5S)-5-[(2R)-2-[(1R;3aS;4E;7aR)-4-[(2Z)-2-[(3S;5R)-3;5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2;3;3a;5;6;7-hexahydro-1H-inden-1-yl]propyl]-3-hydroxy-3-methyloxolan-2-one | CC(CC1CC(C(=O)O1)(C)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C | NA | NA | NA | Q9PTN2; Q1L673; Q28037; O42392; P49701; P11473; P48281; A3RGC1; P13053; Q95MH5; O13124; Q90WN9; Q90WS4 | 20234 | 140 | Tetrahydroxynorbufostane | NA | Tetrahydroxynorbufostane 5-BETA-CHOLESTANE-3-ALPHA7-TETRAOL 5-beta-cholestane-3-alpha;7-alpha;12-alpha;26-tetraol | 436.67 | C27H48O4 | 17-(7-hydroxy-6-methylheptan-2-yl)-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CCCC(C)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C)CO | NA | NA | NA | NA | 20235 | 246983 | Lanosterol | A triterpene that derives from the chair-boat-chair-boat folding of 2;3-oxidosqualene. It is metabolized to CHOLESTEROL and CUCURBITACINS. | Lanosterol Lanosterin Lanster Botalan base 138 Lanosta-8;24-dienol Lanosta-8;24-dien-3beta-ol 8;24-Lanostadien-3beta-ol | 426.72 | C30H50O | (3S;5R;10S;13R;14R;17R)-4;4;10;13;14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2;3;5;6;7;11;12;15;16;17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C | NA | NA | NA | NA | 20236 | 5364803 | 25;26-dihydroxycholecalciferol | RN given refers to (3beta;5A;7E)-isomer | 25;26-Dihydroxyvitamin D3 25;26-dihydroxycholecalciferol 9;10-Secocholesta-5;7;10(19)-triene-3.beta.;25;26-triol 9;10-Secocholesta-5;7;10(19)-triene-3;25;26-triol; (3beta;5Z;7E)- 9;10-Secocholesta- | 416.64 | C27H44O3 | 6-[(4E)-4-[(2E)-2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-2;3;3a;5;6;7-hexahydro-1H-inden-1-yl]-2-methylheptane-1;2-diol | CC(CCCC(C)(CO)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C | NA | NA | NA | NA | 20237 | 160520 | 3;7;12-trihydroxycoprostane | intermediate in bile acid synthesis in liver; enhances rate of porphyrin synthesis in cultured liver cells by induction of delta-aminolevulinic acid synthetase; RN given refers to (3alpha;5beta;7alpha;12alpha)-isomer; structure | Trihydroxycoprostane 3;7;12-Trihydroxycoprostane 5beta-Cholestane-3alpha;7alpha;12alpha-triol 3alpha;7alpha;12alpha-Trihydroxycoprostane 3alpha;7alpha;12alpha-Trihydroxy-5beta-cholestane | 420.67 | C27H48O3 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-10;13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(C)CCCC(C)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20240 | 196302 | 27-norcholestane-3;7;12;24;25;26-hexol | NA | 27-Norcholestane-3;7;12;24;25;26-hexol 27-Nor-5beta-cholestane-3alpha;7alpha;12alpha;24alpha;24xi;25xi;26 -hexol 27-Norcholestane-3;7;12;24;25;26-hexol; N-(N2-(1-(N-(N-(N-(N-(N-(N2-(N-glycyl-L-alph | 454.64 | C26H46O6 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-10;13-dimethyl-17-[(2R)-5;6;7-trihydroxyheptan-2-yl]-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CCC(C(CO)O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20241 | 5284194 | 5 beta-bufol | isolated from gall bladder of toad; identified in patients with cerebrotendinous xanthomatosis | 5beta-Bufol Cholestane-3;7;12;25;26-pentol 5 beta-bufol Cholestane-3;7;12;25;26-pentol; (3alpha;5beta;7alpha;12alpha)- (VAN) 5 beta-bufol | 452.67 | C27H48O5 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-17-[(2R)-6;7-dihydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CCCC(C)(CO)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20242 | 6453659 | Cholestane-3;7;12;24;25-pentol | NA | Cholestane-3;7;12;24;25-pentol 5-beta-Cholestane-3alpha;7alpha;12alpha;24beta;25-pentol Cholestan-3;7;12;24;25-pentol; (3alpha;5beta;7alpha;12alpha;24S)- cholestane-3;7;12;24;25-pentol | 452.67 | C27H48O5 | (3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-17-[(2R;5S)-5;6-dihydroxy-6-methylheptan-2-yl]-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3;7;12-triol | CC(CCC(C(C)(C)O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | NA | NA | NA | NA | 20243 | 5281326 | Fucosterol | major sterol of a marine sponge C. difussa; structure; RN given refers to (3beta;24E)-isomer | Fucosterol Isofucosterol delta5-Avenasterol Stigmasta-5;24(28)-dien-3-ol; (3.beta.;24Z)- | 412.69 | C29H48O | (3S;8S;9S;10R;13R;14S;17R)-10;13-dimethyl-17-[(Z;2R)-5-propan-2-ylhept-5-en-2-yl]-2;3;4;7;8;9;11;12;14;15;16;17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | NA | NA | NA | NA | 20244 | NA | (3a;5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-b-D-Glucopyranosiduronic acid | (3a;5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-b-D-Glucopyranosiduronic acid is a natural human metabolite of Taurolithocholic acid generated in the liver by UDP glucuonyltransferase.Glucuronidation is used to assist in the excretion of toxic substances; drugs or other substances that cannot be | (3a;5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-b-D-Glucopyranosiduronate#Taurolithocholic acid 3-glucuronide#(3a;5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-beta-delta-Glucopyranosiduronate | 659.83 | C32H53NO11S | (3a;5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl b-D-glucopyranosiduronic acid | CC(CCC(=O)NCCS(O)(=O)=O)C1CCC2C3CCC4CC(CCC4(C)C3CCC12C)OC1OC(C(O)C(O)C1O)C(O)=O | NA | NA | NA | NA | 20247 | 439479 | 3;7;12-trihydroxycholestan-26-al | structure in first source | 3;7;12-Trihydroxycholestan-26-al 3alpha;7alpha;12alpha-Trihydroxy-5beta-cholestan-26-al (3alpha;5beta;7alpha;12alpha)-3;7;12-trihydroxycholestan-26-al Cholestan-26-al; 3;7;12-trihydroxy-; (3alpha; | 434.65 | C27H46O4 | (6R)-2-methyl-6-[(3R;5S;7R;8R;9S;10S;12S;13R;14S;17R)-3;7;12-trihydroxy-10;13-dimethyl-2;3;4;5;6;7;8;9;11;12;14;15;16;17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanal | CC(CCCC(C)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C)C=O | NA | NA | NA | NA | 20255 | 54580 | Fluticasone | used in nasal spray for seasonal allergic rhinitis | atemur fluticasone Cultivate Cutivate Flixonase Flixotide Flusonal Fluspiral Flutivate Inalacor | 500.57 | C25H31F3O5S | [(6S;9R;10S;11S;13S;14S;16R;17R)-6;9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10;13;16-trimethyl-3-oxo-6;7;8;11;12;14;15;16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF | NA | NA | NA | P79686; Q6XLJ0; P49115; P04150; P06537; P49843; O73673; Q9N1U3; Q5R9P5; P59667; P06536; P79269; O13186; O46567; P35547; Q95267; P49844; Q3MSN1; Q3MSN4 | 20264 | 9547253 | 1-a;24R;25-Trihydroxyvitamin D2 | NA | (24R)-1alpha;24;25-trihydroxyvitamin D2 (24R)-1alpha;24;25-trihydroxyergocalciferol (5Z;7E;22E)-(1S;3R;24R)-9;10-seco-5;7;10(19);22-ergostatetraene-1; 3;24;25-tetrol | 444.65 | C28H44O4 | (1R;3S;5Z)-5-[(2E)-2-[(1R;3aS;7aR)-1-[(E;2R;5R)-5;6-dihydroxy-5;6-dimethylhept-3-en-2-yl]-7a-methyl-2;3;3a;5;6;7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1;3-diol | CC(C=CC(C)(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C | NA | NA | NA | NA | 20265 | 6446280 | Calcitetrol | NA | calcitetrol (24R)-24-Hydroxycalcitriol 1alpha;24R;25(OH)3D3 1alpha;24R;25-trihydroxyvitamin D3 1-alpha;24(R);25-Trihydroxyvitamin D3 1alpha;24R;25-trihydroxycholecalciferol (1-alpha;3-beta;5Z;7E | 432.64 | C27H44O4 | (1R;3S;5Z)-5-[(2E)-2-[(1R;3aS;7aR)-1-[(2R;5R)-5;6-dihydroxy-6-methylheptan-2-yl]-7a-methyl-2;3;3a;5;6;7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1;3-diol | CC(CCC(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C | NA | NA | NA | NA | |